VEGF induces NO-dependent hyperpermeability in coronary venules

被引:205
作者
Wu, HM
Huang, QB
Yuan, Y
Granger, HJ
机构
[1] TEXAS A&M UNIV, HLTH SCI CTR, DEPT SURG, TEMPLE, TX 76504 USA
[2] TEXAS A&M UNIV, HLTH SCI CTR, MICROCIRCULAT RES INST, TEMPLE, TX 76504 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 1996年 / 271卷 / 06期
关键词
nitric oxide; guanylate cyclase; guanosine; 3'; 5'-cyclic monophosphate-dependent protein kinase; isolated vessel;
D O I
10.1152/ajpheart.1996.271.6.H2735
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to investigate the direct effect of vascular endothelial growth factor (VEGF) on microvascular permeability and its signaling mechanisms. The apparent permeability coefficient to albumin was measured in isolated coronary venules. Topical application of VEGF dose-dependently and transiently increased albumin permeability by two- to threefold. Inhibition of nitric oxide (NO) synthesis with N-G-monomethyl L-arginine abolished VEGF-induced venular hgperpermeability. Furthermore, because NO exerts vasoactive effects through stimulation of guanylate cyclase (GC) and the subsequent production of guanosine 3',5'-cyclic monophosphate (cGMP), we examined the role of GC and cGMP-dependent protein kinase (PKG) in the mediation of VEGF's action. The permeability response to VEGF was measured in the presence of the selective GC inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one and the specific PKC inhibitor KT-5823. Both inhibitors reduced basal permeability and prevented the hyperpermeability response to VEGF. Therefore, we suggest that VEGF modulates microvascular permeability via a signaling cascade involving NO synthesis, GC stimulation, and PKG activation.
引用
收藏
页码:H2735 / H2739
页数:5
相关论文
共 30 条
[1]  
BATES DO, 1996, MICROCIRCULATION, V3, P80
[2]  
BROCK TA, 1991, AM J PATHOL, V138, P213
[3]   CHARACTERIZATION OF THE INCREASE IN VASCULAR-PERMEABILITY INDUCED BY VASCULAR-PERMEABILITY FACTOR INVIVO [J].
COLLINS, PD ;
CONNOLLY, DT ;
WILLIAMS, TJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 109 (01) :195-199
[4]  
CONNOLLY DT, 1989, J BIOL CHEM, V264, P20017
[5]  
CORBIN JD, 1990, ADV SEC MESS PHOSPH, V24, P411
[6]  
DVORAK HF, 1995, AM J PATHOL, V146, P1029
[7]   MOLECULAR AND BIOLOGICAL PROPERTIES OF THE VASCULAR ENDOTHELIAL GROWTH-FACTOR FAMILY OF PROTEINS [J].
FERRARA, N ;
HOUCK, K ;
JAKEMAN, L ;
LEUNG, DW .
ENDOCRINE REVIEWS, 1992, 13 (01) :18-32
[8]  
GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184
[9]  
GRANGER HJ, 1994, PATHOPHYSIOLOGY MICR, P19
[10]   QUANTITATIVE FLUORESCENCE MICROSCOPY ON SINGLE CAPILLARIES - ALPHA-LACTALBUMIN TRANSPORT [J].
HUXLEY, VH ;
CURRY, FE ;
ADAMSON, RH .
AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 252 (01) :H188-H197